Novocure (NVCR) Misses Q2 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Novocure (NVCR) Misses Q2 EPS by 11c

Novocure Reports Second Quarter 2016 Financial Results and Provides Company Update

July 28, 2016 6:30 AM EDT

Continued growth in active patients with 891 active patients at June 30, 2016, an increase of 110 percent from second quarter 2015, and 12 percent from first quarter 2016

Second quarter 2016 reported revenues of $17.9 million, reflecting 174 percent growth versus second quarter 2015 and 37 percent growth versus first quarter 2016

Approximately 116 million covered lives in the United States as of June 30, 2016, including an additional 10 million lives placed under coverage during second quarter 2016

National Comprehensive Cancer Network® (NCCN®) published updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Central Nervous System Cancers to include Optune as category 2A treatment option for newly diagnosed... More